SGH
Sivik Global Healthcare Portfolio holdings
AUM
$224M
This Quarter Return
-2.88%
1 Year Return
+5.3%
3 Year Return
+45.33%
5 Year Return
+103.79%
10 Year Return
+430.94%
AUM
$242M
AUM Growth
+$242M
(+3.8%)
Cap. Flow
+$16.7M
Cap. Flow
% of AUM
6.9%
Top 10 Holdings %
Top 10 Hldgs %
34.33%
Holding
60
New
15
Increased
15
Reduced
14
Closed
11
Top Buys
| 1 |
Centene
CNC
|
$5.89M |
| 2 |
Novo Nordisk
NVO
|
$5M |
| 3 |
Cigna
CI
|
$4.79M |
| 4 |
SPDR S&P Biotech ETF
XBI
|
$4.49M |
| 5 |
Medtronic
MDT
|
$3.88M |
Top Sells
| 1 |
Pfizer
PFE
|
$5.91M |
| 2 |
Eli Lilly
LLY
|
$5.01M |
| 3 |
Becton Dickinson
BDX
|
$4.4M |
| 4 |
Bristol-Myers Squibb
BMY
|
$4.37M |
| 5 |
Molina Healthcare
MOH
|
$3.98M |
Sector Composition
| 1 | Healthcare | 93.04% |
| 2 | Energy | 1.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Cigna
CI
$80.3B
| $4.79M | 1.98% |
+20,000
| New | +$4.79M |
|
27
Baxter International
BAX
$12.7B
| $4.65M | 1.92% |
60,000
-15,000
| -20% | -$1.16M |
|
28
IQVIA
IQV
$32.4B
| $4.62M | 1.91% |
20,000
+5,000
| +33% | +$1.16M |
|
|
29
Medtronic
MDT
$119B
| $3.88M | 1.6% |
+35,000
| New | +$3.88M |
|
30
Option Care Health
OPCH
$4.65B
| $3.71M | 1.53% |
130,000
| – | – |
|
31
Community Health Systems
CYH
$387M
| $3.56M | 1.47% |
300,000
+50,232
| +20% | +$596K |
|
|
AMED
32
DELISTED
Amedisys
AMED
| $3.45M | 1.42% |
+20,000
| New | +$3.45M |
|
|
LHCG
33
DELISTED
LHC Group LLC
LHCG
| $3.37M | 1.39% |
+20,000
| New | +$3.37M |
|
34
Acadia Healthcare
ACHC
$2.12B
| $3.28M | 1.35% |
+50,000
| New | +$3.28M |
|
35
AbbVie
ABBV
$372B
| $3.24M | 1.34% |
20,000
-20,000
| -50% | -$3.24M |
|
36
Surgery Partners
SGRY
$2.91B
| $3.14M | 1.3% |
+57,020
| New | +$3.14M |
|
37
Select Medical
SEM
$1.61B
| $3.12M | 1.29% |
130,000
+40,000
| +44% | +$960K |
|
38
BioMarin Pharmaceuticals
BMRN
$11.2B
| $3.08M | 1.27% |
40,000
| – | – |
|
39
Envista
NVST
$3.52B
| $2.92M | 1.21% |
+60,000
| New | +$2.92M |
|
|
40
Eli Lilly
LLY
$657B
| $2.86M | 1.18% |
10,000
-17,500
| -64% | -$5.01M |
|
41
Incyte
INCY
$16.5B
| $2.78M | 1.15% |
+35,000
| New | +$2.78M |
|
42
Guardant Health
GH
$8.41B
| $2.65M | 1.09% |
40,000
+15,000
| +60% | +$994K |
|
|
SGEN
43
DELISTED
Seagen Inc. Common Stock
SGEN
| $2.52M | 1.04% |
+17,500
| New | +$2.52M |
|
44
Grifois
GRFS
$6.78B
| $2.34M | 0.96% |
+200,000
| New | +$2.34M |
|
45
Cardinal Health
CAH
$35.5B
| $2.27M | 0.94% |
40,000
-20,000
| -33% | -$1.13M |
|
46
Neurocrine Biosciences
NBIX
$13.8B
| $2.11M | 0.87% |
+22,500
| New | +$2.11M |
|
47
Natera
NTRA
$23.1B
| $2.03M | 0.84% |
50,000
+25,000
| +100% | +$1.02M |
|
48
Moderna
MRNA
$9.37B
| $1.72M | 0.71% |
+10,000
| New | +$1.72M |
|
49
BioNTech
BNTX
$24B
| $1.71M | 0.7% |
+10,000
| New | +$1.71M |
|
50
Hologic
HOLX
$14.9B
| – | – |
-40,000
| Closed | -$3.06M |
|